(S)-4'-nitro-Blebbistatin
(Synonyms: (-)-4'-nitro-Blebbistatin, p-nitro-Blebbistatin, para-nitro-Blebbistatin) 目录号 : GC52192A more stable and less phototoxic form of (–)-blebbistatin
Cas No.:1621326-32-6
Sample solution is provided at 25 µL, 10mM.
(S)-4'-nitro-Blebbistatin is a more stable and less phototoxic form of (-)-blebbistatin , which is a selective cell-permeable inhibitor of non-muscle myosin II ATPases.1,2 (-)-Blebbistatin rapidly and reversibly inhibits Mg-ATPase activity and in vitro motility of non-muscle myosin IIA and IIB for several species (IC50s = 0.5-5 µM), while poorly inhibiting smooth muscle myosin (IC50 = 80 µM).3 Through these effects, it blocks apoptosis-related bleb formation, directed cell migration, and cytokinesis in vertebrate cells. However, prolonged exposure to blue light (450-490 nm) results in degradation of blebbistatin to an inactive product via cytotoxic intermediates, which may be problematic for its use in fluorescent live cell imaging applications.4,5 The addition of a 4'-nitro group decreases the inherent fluorescence, stabilizes the molecule to circumvent its degradation by prolonged blue light exposure, and decreases its phototoxicity while retaining the in vitro and in vivo activity of (-)-blebbistatin.6,7 (S)-4'-nitro-Blebbistatin has the same stereochemistry as the active (-)-blebbistatin enantiomer.
1.Straight, A.F., Cheung, A., Limouze, J., et al.Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitorScience299(5613)1743-1747(2003) 2.KovÁcs, M., TÓth, J., HetÉnyi, C., et al.Mechanism of blebbistatin inhibition of myosin IIJ. Biol. Chem.279(34)35557-35563(2004) 3.Limouze, J., Straight, A.F., Mitchison, T., et al.Specificity of blebbistatin, an inhibitor of myosin IIJ. Muscle Res. Cell Motil.25(4-5)337-341(2004) 4.Kolega, J.Phototoxicity and photoinactivation of blebbistatin in UV and visible lightBiochem. Biophys. Res. Commun.320(3)1020-1025(2004) 5.Sakamoto, T., Limouze, J., Combs, C.A., et al.Blebbistatin, a myosin II inhibitor, is photoinactivated by blue lightBiochemistry44(2)584-588(2005) 6.KÉpirÓ, M., VÁrkuti, B.H., VÉgner, L., et al.para-Nitroblebbistatin, the non-cytotoxic and photostable myosin II inhibitorAngew Chem. Int. Ed. Engl.53(31)8211-8215(2014) 7.Verhasselt, S., Roman, B.I., Bracke, M.E., et al.Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogsEur. J. Med. Chem.13685-103(2017)
Cas No. | 1621326-32-6 | SDF | Download SDF |
别名 | (-)-4'-nitro-Blebbistatin, p-nitro-Blebbistatin, para-nitro-Blebbistatin | ||
Canonical SMILES | O=C1[C@@]2(O)C(N(C3=CC=C([N+]([O-])=O)C=C3)CC2)=NC4=C1C=C(C)C=C4 | ||
分子式 | C18H15N3O4 | 分子量 | 337.3 |
溶解度 | DMF: 20 mg/ml,DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml,DMSO: 12.5 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.9647 mL | 14.8236 mL | 29.6472 mL |
5 mM | 0.5929 mL | 2.9647 mL | 5.9294 mL |
10 mM | 0.2965 mL | 1.4824 mL | 2.9647 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet